What does custom OEM manufacturing cost?

Pricing for medical device contract manufacturing—from prototypes to volume production

Custom OEM manufacturing for medical devices operates on a cost structure fundamentally different from buying equipment off-the-shelf. You're not paying a single list price; you're negotiating tooling, non-recurring engineering (NRE), materials, labor, overhead, and quality system costs—each of which varies dramatically based on device complexity, volume, and regulatory class. Materials and components typically account for 20-50% of overall manufacturing costs, while processing and assembly time accounts for another 20-50%. The real challenge is that the cost of manufacturing a new medical device can range from a few thousand dollars to several million dollars depending on classification and intended use.

MedSource does not yet have proprietary quote data for custom OEM manufacturing. This article synthesizes publicly available pricing frameworks, manufacturer fee structures, and industry cost models to help procurement teams benchmark expectations and negotiate effectively.

What the typical range is

Contract manufacturing pricing splits into two components: one-time NRE (non-recurring engineering) and per-unit manufacturing cost.

Providers typically quote bids based on labor, tooling, and materials. For a Class II medical device with moderate complexity:

• Simple Class I devices (minimal assembly, no custom tooling): $20,000–$100,000 in NRE; unit costs $0.50–$5.
• Mid-complexity Class II devices (some custom molding or assembly): $100,000–$500,000 in NRE; unit costs $5–$50 depending on volume.
• Complex Class II/III devices (custom fixtures, cleanroom validation, sterilization): $250,000–$2+ million in NRE; unit costs $50–$500+.

The average total cost for a 510(k) device (Class II) from concept to clearance was approximately $31 million, with $24 million spent on FDA-dependent activities. However, this reflects full development, not manufacturing alone. Development and engineering costs comprise approximately $2–5 million of the total. Manufacturing setup, tooling, and pilot production runs occupy $100,000 to $1 million.

What pushes price up — features, certifications, support tier

Custom tooling and molds. Tooling costs can range from a few thousand dollars for simple injection molded plastic parts to several hundred thousand dollars for more complex metal components.

High-precision molds and automated assembly equipment drive significant capital outlay, especially for complex Class II devices.

Overhead allocated to low-volume runs. Low-complexity, high-volume consumables incur 20–50% manufacturing overhead; mid-complexity devices 40–80%; and high-complexity or low-volume Class II/III devices with custom tooling, cleanrooms, and validation 60–150% or higher. Early production batches absorb more overhead per unit.

ISO 13485 and FDA compliance infrastructure. Medical device contract manufacturers need ISO 13485 and FDA registration; they must follow FDA quality rules (21 CFR Part 820).

A quick rule of thumb is to double the assembly labor to estimate overhead, or if assembly labor is not known, double the bill-of-materials cost to estimate total cost of ownership.

Sterilization, packaging, and validation. Clean-room lease for medical device manufacturing is a recurring $45,000 per month occupancy cost. Sterilization methods (EtO, gamma, steam) and validated packaging add $10,000–$100,000+ per run depending on volume.

Regulatory testing and design transfer. Programming fees for production machines (selective solder, reflow, inspection) are NRE costs; unless the design revises, the programming is reused for every production run.

What pushes price down — refurbished, older generation, lease, GPO contracts

Off-the-shelf components and standard assembly processes. Using off-the-shelf parts and materials saves design and prototyping time, as well as any new tooling that may be required.

Higher volumes. Low or variable volumes limit economies of scale, while scrap, rework, or low first-pass yields quickly inflate unit costs. Annual volumes of 50,000+ units reduce per-unit cost by 30–50% compared to pilot runs of 1,000–5,000 units.

Design for Manufacturability (DfM) engagement early. Engage manufacturing engineers early to simplify part geometry, minimize fasteners, and select cost-effective materials, reducing labor minutes and scrap rates. This can trim manufacturing cost by 15–30%.

Automation and process optimization. Effective automation and improvements in tooling could save more than 50% of medical device manufacturing costs. However, this requires upfront CapEx and higher volumes to amortize.

Shared facility capacity. Manufacturers with excess cleanroom or assembly capacity may offer lower per-unit labor rates if you commit to consistent monthly volumes.

Hidden costs — install, training, calibration, consumables, service contracts

Quality system overhead and regulatory documentation. Quality systems & regulatory overhead includes QMS maintenance, document control, audits, CAPA support; validation and qualification (IQ/OQ/PQ, process validation) often represent large one-time costs amortized across units.

Change orders and design revisions. Once production begins, any design change triggers new fixturing, test method re-validation, and potential rework. Budget 5–10% contingency for this.

Vendor qualification and incoming inspection. Vendors need to be approved and qualified; this may require site visits or diving into the vendor's quality system; quoting can take time, as can working out supply agreements for lot releases, vendor QC checks, labeling, ordering, and shipping.

Retained samples and destructive testing. Retained first and last products of every batch, plus two to three samples for lab testing (bioburden, EtO residuals), are typical quality holds. These costs are per-batch, not per-unit.

Scrap, setup waste, and first-article inspection. Injection molding machines require an amount of material before 'at specification' production is reached; if your material is £5/kg and 3kg is used at start-up, £15 has been used before you have any effective product. Setup waste can easily add 3–5% to early-run costs.

Sterilization validation and lot release testing. Sterilization and packaging processes occur in a regulated ISO Class 8 clean room. Validation studies (media fills, biological indicators) and periodic audit sterility testing add $5,000–$50,000 per qualification campaign.

How to negotiate — concrete tactics

1. Request detailed cost breakdowns. Ask the manufacturer to itemize NRE, tooling ownership, labor rates (per hour or per unit), material costs, and overhead allocation. Do not accept black-box quotes.

2. Own the tooling. If tooling is 100% owned by the EMS provider and then he also uses it for other customers, it should never be an NRE. Negotiate purchase or lease of molds and fixtures directly from the tool maker.

3. Clarify NRE amortization. View NREs as one-time costs for something that gets consumed over time, yet they may not be directly or 100% correlated with every unit in your program; NRE often gets amortized based on OEM program quantities built. Push back on amortization schedules that assume volumes you don't commit to.

4. Lock in material pricing with long-term contracts. Lock in exchange rates for overseas purchases and secure long-term contracts on critical alloys or resins to protect against volatility.

5. Demand DfM workshops early. Negotiate cost-reduction activities before tooling is finalized. A 10% design simplification saves 20%+ in manufacturing.

6. Compare labor rates geographically. North America ($80–$170/hour burdened labor) versus Southeast Asia ($10–$30/hour) creates 60–80% cost deltas for labor-intensive assembly. However, North America has the most stringent standards and regulations for medical devices in the world, so nearshoring trade-offs include faster problem resolution and lower NRE risk.

7. Negotiate volume discounts explicitly. Request tiered pricing: e.g., $15/unit at 10,000/year, $12/unit at 25,000/year, $10/unit at 50,000/year. Get this in writing in your manufacturing agreement.

When the price feels off — red flags

• NRE charged but tooling owned by manufacturer. If you pay $200,000 NRE and the manufacturer owns the mold and uses it for competitors, you've subsidized their asset. Require IP transfer or ownership escrow.

• Overhead allocated as a fixed percentage without breakdown. Standard overhead is 40–100% of direct labor for medical devices, but not all manufacturers are transparent. Request a witness audit of their facility overhead (equipment depreciation, quality staff, facility rent, utility).

• Pilot-run unit costs inflated 300%+ over production volume. Initial runs naturally cost more (higher scrap, lower efficiency), but a 3× multiplier signals either poor planning or hidden waste. Expect 1.5–2.5× for Class II devices.

• No mention of quality system costs. A quote of $5/unit for assembly that excludes calibration, inspection, and validation overhead is incomplete. Inspecting parts requires calibrated equipment and trained staff.

• Sterilization and packaging vague. These are often significant line items. Demand separate quotes for sterilization method (EtO, gamma, steam), validation (IQ/OQ/PQ), and each batch's sterility assurance level (SAL).

• No lead time or delivery schedule defined. Contract manufacturers often quote price but bury timeline assumptions. Tight timelines (e.g., 4 weeks vs. 12 weeks) inflate costs due to overtime and expedited material handling.

Sources

• StarFish Medical (2020). How Much Does It Cost to Develop a Medical Device? Survey of 200+ medical device companies on development and manufacturing costs by FDA class.

• Meridian Medical (2025). Key Factors Influencing Medical Device Manufacturing Costs. Breakdown of materials, labor, overhead, and scrap in quality system context.

• Complizen (2025). How Much Does It Cost to Bring a Medical Device to Market? 2025 Budget Guide. Class-specific cost ranges and budget allocation by phase (clinical, regulatory, manufacturing, commercialization).

• FDA 21 CFR 820 (Quality System Regulation). Mandatory manufacturing practices and controls that underpin all OEM cost models.

• VentureOutsource (2026). Contract Manufacturing NRE Strategy for Electronic OEMs. Analysis of tooling ownership, amortization, and cost-negotiation best practices.

• ISO 13485:2016. International quality management system standard for medical device manufacturers and OEMs—certification cost baseline for facility overhead.

---

Note: This article reflects publicly available pricing frameworks and industry survey data as of May 2026. Actual quotes vary by device type, volume, geography, and regulatory pathway. MedSource will update this article as proprietary bid data accumulates from procurement partnerships. For device-specific cost modeling, request formal quotes from 3–5 ISO 13485–certified contract manufacturers and conduct a cost-plus audit on the three lowest bids.